03/12/2024

DLA Piper advises GigCapital5

QT Imaging engages in the research, development, and commercialization of innovative body imaging systems

03/12/2024

DLA Piper advises Haemonetics

The acquisition is subject to customary closing conditions and is expected to be completed in the first quarter of Haemonetics' fiscal year 2025.